Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 8, 2009, Pages 706-714

  Favaloro, Emmanuel J ^a   Mohammed, Soma ^a   Koutts, Jerry ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Factor VIII; Factor VIII binding assay; Type 2N; Von Willebrand disease; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; AUSTRALIA; BLEEDING TENDENCY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; FAMILY STUDY; FEMALE; GEOGRAPHY; HEMOPHILIA; HUMAN; INCIDENCE; MALE; PATIENT IDENTIFICATION; PREVALENCE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2N;

AUSTRALIA; FACTOR VIII; HUMANS; MASS SCREENING; PREVALENCE; VON WILLEBRAND DISEASES;

EID: 70449584919     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328332d022     Document Type: Article

References (29)

1. Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, et al., and the Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: A report of the subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4:2103-2114.
2. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JWC. Reassessment of ABO-blood group, gender and age on laboratory parameters used to diagnose von Willebrand disorder (VWD): Potential influence on the diagnosis versus the potential association with risk of thrombosis. Am J Clin Pathol 2005; 124:910-917.
3. Favaloro EJ. Laboratory identification of von Willebrand disease: Technical and scientific perspectives. Semin Thromb Hemost 2006; 32:456-471.
4. Favaloro EJ. Towards a new paradigm for the identification and functional characterisation of von Willebrand disease. Semin Thromb Hemost 2009; 35:60-75.
5. Nishino M, Girma J-P, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74:1591-1599.
6. Rodgers SE, Lerda NV, Favaloro EJ, Duncan EM, Casey GJ, Quinn DM, et al. Identification of von Willebrand's disorder type 2N (Normandy) in Australia: A cross-laboratory investigation using different methodologies. Am J Clin Pathol 2002; 118:269-276.
7. Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE, Peake IR. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques. Thromb Haemost 1996; 75:959-964.
8. Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 1996; 76:598-602.
9. Adcock DM, Hoefner DM, Kottke-Marchant K, Marlar RA, Szamosi DI, Warunek DJ. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: Approved Guideline. 5th ed. CLSI document H21-A5. Wayne, PA: Clinical Laboratory Standards Institute; 2008.
10. Favaloro EJ, Grispo L, Exner T, Koutts J. Development of a simple collagen binding assay aids in the diagnosis of, and permits sensitive discrimination between, type I and type II von Willebrand's disease. Blood Coagul Fibrinolysis 1991; 2:285-291.
11. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Crosslaboratory audit of normal reference ranges and assessment of ABO-blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis 2005; 16:597-605.
12. Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Meiring M, et al. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thromb Res 2009; 123:862-868.
13. Favaloro EJ, Thom J, Patterson D, Just S, Baccala M, Dixon T, et al. Potential supplementary utility of combined PFA-100 and functional VWF testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease. Blood Coagul Fibrinolysis 2009; 20:475-483.
14. Favaloro EJ. Phenotypic identification of platelet type-von Willebrand disease and its discrimination from type 2B von Willebrand disease: A question of 2B or not 2B? A story of nonidentical twins? Or two-sides of a multidenominational or multifaceted primary haemostasis coin? Semin Thromb Hemost 2008; 34:113-127.
15. Zhang L, Li H, Zhao H, Zhang X, Ji L, Yang R. Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese institute. Haemophilia 2003; 9:696-702.
16. Trasi S, Shetty S, Ghosh K, Mohanty D. Prevalence and spectrum of von Willebrand disease from western India. Indian J Med Res 2005; 121:653-658.
17. Iorio A, Oliovecchio E, Morfini M, Mannucci PM, Association of Italian Hemophilia Centres Directors. Collaborators (68). Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. Haemophilia 2008; 14:444-453.
18. Tagliaferri A, Rivolta GF, Biasoli C, Valdré L, Rodorigo G, D'Incá M, et al. A web-based registry of inherited bleeding disorders in the region of Emilia- Romagna: Results at three and a half years. Haemophilia 2008; 14:343-354.
19. Registry of Congenital Bleeding Disorders in the Region of Emilia- Romagna. http://www.registroemofiliarer.it [Accessed 24 May 2009].
20. Canadian Hemophilia Registry. http://fhs.mcmaster.ca/chr/pdf/09/ CHRIX090413.pdf [Accessed 24 May 2009].
21. Woods AI, Meschengieser SS, Blanco AN, Salviú MJ, Faŕas CE, Kempfer AC, Lazzari MA. Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease. Haematologica 2001; 86:420-427.
22. Rezende SM, Pinheiro K, Caram C, Genovez G, Barca D. Registry of inherited coagulopathies in Brazil: first report. Haemophilia 2009; 15:142-149.
23. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: The leading causes of diagnostic error in haemostasis? Semin Thromb Hemost 2008; 34:612-634.
24. Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost 2005; 31:569-576. (Pubitemid 41642571)
25. Gupta PK, Charan VD, Saxena R. Spectrum of von Willebrand disease and inherited platelet function disorders amongst Indian bleeders. Ann Hematol 2007; 86:403-407.
26. Ghosh K, Trasi S, Shetty S, Mohanty D. Use of a new enzyme-linked immunosorbent assay for the detection of type 2N von Willebrand disease and its prevalence in an Indian population. Blood Coagul Fibrinolysis 2006; 17:7-11.
27. Morales-De la Vega A, Reyes-Maldonado E, Mart́nez-Murillo C, Quintana- Gonzá lez S. Type 2N von Willebrand disease (Normandy). Rev Med Inst Mex Seguro Soc 2008; 46:55-62.
28. Mazurier C, Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease: Results of an international survey. Thromb Haemost 1996; 76:270-274.
29. Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Baker R, Hertzberg M, et al., on behalf of the RCPA QAP in Haematology. Reducing errors in identification of von Willebrand disease: The experience of the Royal college of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2006; 32:505-513.